Insulin-like growth factor binding protein-2 regulates β-catenin signaling pathway in glioma cells and together contributes to poor patient prognosis

Abstract

IGFBP-2 potentiates GBM tumor growth by the activation of the β-catenin pathway through its C-terminal domain, and their coexpression possibly contributes to worse patient prognosis.